Athanasios Tsiatis
Hoofd Techniek/Wetenschap/O&O bij ALX ONCOLOGY HOLDINGS INC.
Profiel
Athanasios Tsiatis is currently the Senior Vice President-Clinical Development at ALX Oncology Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Plexxikon, Inc. from 2018 to 2021.
He completed his undergraduate degree at New York University and obtained his doctorate from Vanderbilt University School of Medicine.
Actieve functies van Athanasios Tsiatis
| Bedrijven | Functie | Begin |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
Eerdere bekende functies van Athanasios Tsiatis
| Bedrijven | Functie | Einde |
|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
Opleiding van Athanasios Tsiatis
| New York University | Undergraduate Degree |
| Vanderbilt University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Commercial Services |
